Lupin receives USFDA approval for calcipotriene topical solution
Lupin Ltd has received final USFDA approval for its generic version of Dovonex scalp solution used in treatment of psoriasis of scalp. The drug calcipotriene […]
Lupin Ltd has received final USFDA approval for its generic version of Dovonex scalp solution used in treatment of psoriasis of scalp. The drug calcipotriene […]
Orchid Pharma has received final USFDA approval for Aripiprazole Orally-Disintegrating tablets, used in treatment of schizophrenia and bipolar disorder. The drug will be made available […]
Zydus Cadila has received final USFDA approval to market Ethacrynate sodium for injection, used to reduce swelling caused by various diseases. The company will market […]
Zydus Cadila has received final USFDA approval to market minocycline hydrochloride extended release tablets used to treat acne. The company will market the drug in […]
Dr. Reddy s Laboratories Ltd has launched Clofarabine Injection, a therapeutic equivalent generic version of Clolar (clofarabine) Injection in the United States market. The company […]
Lupin has received final USFDA approval to market generic Nadolol tablets, used for treatment of hypertension, in the American market. The drug will be marketed […]
Ajanta Pharma has received final USFDA approval for Entacapone tablets to market the same in USA. It is a bioequivalent generic version of Comtan tablets. […]
Zydus Cadila has received final USFDA approval to market aspirin and extended release dipyridamole capsules, which is used to prevent excessive blood clotting and reduce […]
Jubilant Life Sciences has received final USFDA approval for the generic version of its non-steroidal anti-inflammatory drug, Indocin. The approval for Indomethacin capsules is a […]
Zydus Cadila has received final USFDA approval to market candesartan cilexetil tablets used for treatment of hypertension. The company will market the drug in the […]
Copyright © 2024 | WordPress Theme by MH Themes